Testing effectiveness (Phase 2)UnknownNCT05966025
What this trial is testing
Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD)
Who this might be right for
Fatty Liver DiseaseFatty Liver
October 6 University 60